-35.92 -49.26 Cost of constuction 31.40 63.28 -31.88 -50.38 Cost of services 0.00 3.79 -3.79 -100.00 Administrative expenses 24.98 13.12 11.86 90.40 Finance cost 2.60 3.48 -0.88 -25.29 58.98 83.67 -24.69
December 31, 2018 Financial Statement Consolidate financial statement % revenue from sales 2018 2017 increase(decrease) 2018 2017 Revenues from sales 175.66 295.89 (120.23 ) (40.63%) 100.00% 100.00% Cost of
, 2019 Financial Statement Consolidate financial statement % revenue from sales Q4/2019 Q4/2018 increase(decrease) Q4/2019 Q4/2018 Revenues from sales 218.50 175.66 42.84 24.39% 100.00% 100.00% Cost of
, 2018 Financial Statement Consolidate financial statement % revenue from sales 2018 2017 increase(decrease) 2018 2017 Revenues from sales 175.66 295.89 (120.23 ) (40.63%) 100.00% 100.00% Cost of sales
revenue from sales and services amounted to Baht 7,815 million, decreased by Baht 334 million or 4% QoQ. This result from the decrease in sale volume and selling price while increase in production cost both
1,403.07 13% Cost of hospital operations 276.11 258.34 7% 1,101.98 985.67 12% Gross margin 117.88 108.76 8% 485.45 417.39 16% % Gross margin 30% 30% 0% 31% 30% 1% Administrative expenses 41.54 40.51 3
approved the sale of Takuni Land’s shares including approved Takuni Land to purchase the land from a director of the company to be as an access road for the Project (which included in the development cost
the sale of Takuni Land’s shares including approved Takuni Land to purchase the land from a director of the company to be as an access road for the Project (which included in the development cost) as
to long-term shareholder value generation laying the foundations of future improved results via new product development (introduction of dolomitic product line) and cost saving measures (Solar project
current investment which is cash received from the private placement capital increase in Q1/2018. 2. Cost of sale , Profit margin In Q1/2018 the company had cost of sale Baht 78.13 million compare with the